The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease
Open accessAbstract
The bis-indole indirubin is an active ingredient of Danggui Longhui Wan, a traditional Chinese medicine recipe used in the treatment of chronic diseases such as leukemias. The antitumoral properties of indirubin appear to correlate with their antimitotic effects. Indirubins were recently described as potent (IC(50): 50-100 nm) inhibitors of cyclin-dependent kinases (CDKs). We report here that indirubins are also powerful inhibitors (IC(50): 5-50 nm) of an evolutionarily related kinase, glycogen synthase kinase-3beta (GSK-3 beta). Testing of a series of indoles and bis-indoles against GSK-3 beta, CDK1/cyclin B, and CDK5/p25 shows that only indirubins inhibit these kinases. The structure-activity relationship study also suggests that indirubins bind to GSK-3 beta's ATP binding pocket in a way similar to their binding to CDKs, the details of which were recently revealed by crystallographic analysis. GSK-3 beta, along with CDK5, is responsible for most of the abnormal hyperphosphorylation of the microtubule-binding protein tau observed in Alzheimer's disease. Indirubin-3'-monoxime inhibits tau phosphorylation in vitro and in vivo at Alzheimer's disease-specific sites. Indirubins may thus have important implications in the study and treatment of neurodegenerative disorders. Indirubin-3'-monoxime also inhibits the in vivo phosphorylation of DARPP-32 by CDK5 on Thr-75, thereby mimicking one of the effects of dopamine in the striatum. Finally, we show that many, but not all, reported CDK inhibitors are powerful inhibitors of GSK-3 beta. To which extent these GSK-3 beta effects of CDK inhibitors actually contribute to their antimitotic and antitumoral properties remains to be determined. Indirubins constitute the first family of low nanomolar inhibitors of GSK-3 beta to be described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanks, S. K., & Hunter, T. R. (1995) · PubMed · Cited by 2,518
The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1
Hanks, S. K., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768349 · Cited by 2,318
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L.-H. (1999) · Nature · doi:10.1038/45159 · Cited by 1,545
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Self-citationYost, C., Torres, M., Miller, J. R., Huang, E., Kimelman, D., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.12.1443 · Cited by 1,165
Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine
Tang, W., & Eisenbrand, G. (1992) · Springer eBooks · doi:10.1007/978-3-642-73739-8 · Cited by 992
Self-citationMandelkow, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01368-3 · Cited by 953
Self-citationThe cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862
Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820
Self-citationHoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., et al. (1999) · Nature Cell Biology · doi:10.1038/9035 · Cited by 809
Self-citationExploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L., Thunnissen, A.-M. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Self-citationBiernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796
Self-citationβ-catenin: a key mediator of Wnt signaling
Willert, K., & Nusse, R. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80068-3 · Cited by 753
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
Veselý, J., Havliček, L., Strnad, M., Blow, J. J., Donella‐Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00771.x · Cited by 632
Self-citationCarlson, B. A., Dubay, M., Sausville, E. A., Brizuela, L., & Worland, P. J. (1996) · PubMed · Cited by 580
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L.-H., Kwon, Y. T., Girault, J.-A., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 552
Self-citationGlycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos
He, X., Saint-Jeannet, J.-P., Woodgett, J. R., Varmus, H. E., & Dawid, I. B. (1995) · Nature · doi:10.1038/374617a0 · Cited by 490
Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 469
Meijer, L., Thunnissen, A.-M., White, A., Garnier, M., Nikolic, M., Tsai, L.-H., Walter, J., Cleverley, K., Salinas, P., Wu, Y.-Z., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00063-6 · Cited by 454
Self-citationChinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine
Tang, W., & Eisenbrand, G. (1992) · Cited by 453
Self-citationBidirectional Regulation of DARPP-32 Phosphorylation by Dopamine
Nishi, A., Snyder, G. L., & Greengard, P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08147.1997 · Cited by 424
Self-citationPresenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9637 · Cited by 409
Senderowicz, A. M., Headlee, D., Stinson, S. F., Lush, R. M., Kalil, N., Villalba, L., Hill, K., Steinberg, S. M., Figg, W. D., Tompkins, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2986 · Cited by 403
Human Medicinal Agents from Plants
(1993) · ACS Symposium Series · doi:10.1021/bk-1993-0534 · Cited by 367
Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275
Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., & Worland, P. J. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1742 · Cited by 345
Schultz, C., Link, A., Leost, M., Zaharevitz, D. W., Gussio, R., Sausville, E. A., Meijer, L., & Kunick, C. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900570 · Cited by 334
Self-citationLithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
Muñoz-Montaño, J. R., Moreno, F. J., Avila, J., & Dı́az-Nido, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00688-1 · Cited by 322
Zheng‐Fischhöfer, Q., Biernat, J., Mandelkow, E., Illenberger, S., Godemann, R., & Mandelkow, E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520542.x · Cited by 321
Self-citationLucas, F. R., Goold, R. G., Gordon-Weeks, P. R., & Salinas, P. C. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.10.1351 · Cited by 301
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 288
Takashima, A., Honda, T., Yasutake, K., Michel, G., Murayama, O., Murayama, M., Ishiguro, K., & Yamaguchi, H. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00061-3 · Cited by 287
Chang, Y.-T., Gray, N. S., Rosania, G. R., Sutherlin, D. P., Kwon, S., Norman, T. C., Sarohia, R., Leost, M., Meijer, L., & Schultz, P. G. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80048-9 · Cited by 268
Self-citationATP-site Directed Inhibitors of Cyclin-dependent Kinases
G ray, N., Detivaud, L., Doerig, C., & Meijer, L. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730609220401152358 · Cited by 266
Self-citationProgress in Cell Cycle Research
(1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7 · Cited by 237
Zaharevitz, D. W., Gussio, R., Leost, M., Senderowicz, A. M., Lahusen, T. J., Kunick, C., Meijer, L., & Sausville, E. A. (1999) · PubMed · Cited by 225
Self-citationButyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
Kitagawa, M., Okabe, T., Ogino, H., et al. (1993) · PubMed · Cited by 221
Chinese drugs of plant origin—chemistry, pharmacology and use in traditional and modern medicine
Phillipson, J. D. (1993) · Phytochemistry · doi:10.1016/0031-9422(93)85263-q · Cited by 216
The Role of Glycogen Synthase Kinase 3β in Insulin-stimulated Glucose Metabolism
Summers, S. A., Kao, A. W., Kohn, A. D., Backus, G. S., Roth, R. A., Pessin, J. E., & Birnbaum, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17934 · Cited by 212
Bible, K. C., & Kaufmann, S. H. (1996) · PubMed · Cited by 189
UCN-01, a selective inhibitor of protein kinase C from Streptomyces.
TAKAHASHI, I., KOBAYASHI, E., ASANO, K., YOSHIDA, M., & NAKANO, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1782 · Cited by 186
GSK3β/shaggy mediates patterning along the animal-vegetal axis of the sea urchin embryo
Emily-Fenouil, F., Ghiglione, C., Lhomond, G., Lepage, T., & Gache, C. (1998) · Development · doi:10.1242/dev.125.13.2489 · Cited by 171
Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain
Lee, K.-Y., Clark, A. W., Rosales, J. L., Chapman, K., Fung, T., & Johnston, R. N. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00026-7 · Cited by 168
Lovestone, S., Davis, D. R., Webster, M.-T., Kaech, S., Brion, J., Matus, A. I., & Anderton, B. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00183-8 · Cited by 166
Maggirwar, S. B., Tong, N., Ramirez, S., Gelbard, H. A., & Dewhurst, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730578.x · Cited by 164
ALZHEIMER'S DISEASE AND RELATED DISORDERS
Raskind, M. A., & Peskind, E. R. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70341-2 · Cited by 161
Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
Sengupta, A., Wu, Q., Grundke-Iqbal, I., Iqbal, K., & Singh, T. J. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006883924775 · Cited by 160
Cohen, P. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0399 · Cited by 158
Akiyama, T., Yoshida, T., Tsujita, T., Shimizu, M., Mizukami, T., Okabe, M., & Akinaga, S. (1997) · PubMed · Cited by 152
CDK inhibition and cancer therapy
Garrett, M. D., & Fattaey, A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80015-x · Cited by 151
Biernat, J., & Mandelkow, E.-M. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.3.727 · Cited by 149
Self-citationChemical inhibitors of cyclin-dependent kinases
Meijer, L., & Kim, S. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)83011-x · Cited by 140
Self-citationRegulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation
Sharma, P., Sharma, M., Amin, N. D., Albers, R. W., & Pant, H. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11156 · Cited by 131
Godemann, R., Biernat, J., Mandelkow, E., & Mandelkow�, E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00741-3 · Cited by 122
Self-citationAlzheimer's disease and related disorders
(1990) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(90)90072-r · Cited by 118
Yu, L., Orlandi, L., Wang, P., Orr, M. S., Senderowicz, A. M., Sausville, E. A., Silvestrini, R., Watanabe, N., Piwnica-Worms, H. M., & O'Connor, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33455 · Cited by 98
Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators
Tang, D., & Wang, J. H.-C. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_20 · Cited by 78
Rialet, V., & Meijer, L. (1991) · PubMed · Cited by 65
Self-citationHughes, K., Pulverer, B., Theocharous, P., & Woodgett, J. R. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb19860.x · Cited by 55
Proteolysis by presenilins and the renaissance of tau
Haass, C., & Mandelkow, E. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01576-7 · Cited by 20
Self-citation
Cited by
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
Protein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
Metadata
- Authors
- Leclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y.-Z., Mandelkow, E.-M., Eisenbrand, G., & Meijer, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 276
- Issue
- 1
- Pages
- 251-260
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2104373322
- Cited by
- 723
- References
- 61
- FWCI
- 20.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.